# Central Nervous System (CNS) Agents: Anti-Migraine Agents, Acute

## Length Of Authorizations

180 Days

## Prior Authorization Criteria

- Is there any reason the patient cannot be changed to a medication not requiring prior approval?

  Acceptable reasons include:

  - Allergy to preferred medications
  - Contraindication to all preferred medications
  - History of unacceptable/toxic side effects to at least two preferred medications

## Step Therapy Approval Criteria

- For a drug requiring step therapy, there must have been inadequate clinical response to preferred alternatives, including a trial of at least 14 days with at least two medications not requiring prior approval
- For a non-preferred drug, there must have been inadequate clinical response to preferred alternatives, including a trial of at least 14 days with at least one medication requiring step therapy

Nurtec ODT quantity limit is 8 per 30 days

## Anti-Migraine Agents, Acute

Central Nervous System (CNS) Agents: Anti-Migraine Agents, Acute

| PREFERRED | NON-PREFERRED |
| :--- | ---: |
| Naratriptan QL    | Almotriptan          |
| Nurtec ODT QL, ST | Dihydroergotamine    |
| Rizatriptan QL    | Eletriptan           |
| Sumatriptan QL    | Ergomar              |
|                   | Frovatriptan         |
|                   | Migergot             |
|                   | Onzetra Xsail QL     |
|                   | Reyvow               |
|                   | Sumatriptan/Naproxen |
|                   | Tosymra QL           |
|                   | Trudhesa             |
|                   | Ubrelvy              |
|                   | Zolmitriptan         |

### Link to Criteria

[Central Nervous System (CNS) Agents: Anti-Migraine Agents, Acute](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=22)
